Omega Therapeutics Inc (OMGA)
0.786
+0.01
(+1.29%)
USD |
NASDAQ |
Nov 22, 16:00
0.765
-0.02
(-2.67%)
After-Hours: 20:00
Omega Therapeutics Shareholders Equity (Quarterly): 11.54M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.54M |
| June 30, 2024 | 26.26M |
| March 31, 2024 | 41.35M |
| December 31, 2023 | 58.02M |
| September 30, 2023 | 76.04M |
| June 30, 2023 | 95.92M |
| March 31, 2023 | 123.00M |
| December 31, 2022 | 105.97M |
| Date | Value |
|---|---|
| September 30, 2022 | 133.65M |
| June 30, 2022 | 157.38M |
| March 31, 2022 | 181.35M |
| December 31, 2021 | 200.63M |
| September 30, 2021 | 220.34M |
| June 30, 2021 | -92.48M |
| March 31, 2021 | -77.88M |
| December 31, 2020 | -64.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-92.48M
Minimum
Jun 2021
220.34M
Maximum
Sep 2021
74.78M
Average
85.98M
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna Inc | 11.93B |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.73M |
| Total Liabilities (Quarterly) | 141.18M |
| Debt to Equity Ratio | 1.350 |
| Current Ratio | 1.611 |
| Net Debt Paydown Yield | 1.30% |